<p>A. <i>PIK3CA</i> mutations. B. <i>KRAS</i> mutations. C. <i>NRAS</i> mutations. D. <i>BRAF</i> mutations.</p
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Ras is frequently mutated in cancer, however, there is a lack of consensus in the literature regardi...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
<p>The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p
<p>Frequency and percentage of <i>KRAS</i> and <i>BRAF</i> mutations in normal (N), low-grade dyspla...
<p>Panel A: PIK3CA mutations (exon9: n = 643; exon20: n = 636). Panel B: NRAS mutations (codons12 & ...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>Cosmic DB = Cosmic d...
<p>Panel A: KRAS mutations (codons12 & 13: n = 674; codon61: n = 672). Panel B: BRAF mutations (exon...
<p>Frequencies of tumor <i>KRAS</i>, <i>BRAF</i>, and <i>PIK3CA</i> point mutations and <i>ERBB2</i>...
<p>(A) Numbers of missense and nonsense mutations were compared between tumors with or without <i>NL...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
KRAS mutation testing is mandatory for patients with metastatic colorectal cancer who are eligible f...
<p>*N, total number of samples with mutation, <sup>§</sup>INS/DEL in the remaining cases.</p><p>Freq...
Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic ...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Ras is frequently mutated in cancer, however, there is a lack of consensus in the literature regardi...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
<p>The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p
<p>Frequency and percentage of <i>KRAS</i> and <i>BRAF</i> mutations in normal (N), low-grade dyspla...
<p>Panel A: PIK3CA mutations (exon9: n = 643; exon20: n = 636). Panel B: NRAS mutations (codons12 & ...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>Cosmic DB = Cosmic d...
<p>Panel A: KRAS mutations (codons12 & 13: n = 674; codon61: n = 672). Panel B: BRAF mutations (exon...
<p>Frequencies of tumor <i>KRAS</i>, <i>BRAF</i>, and <i>PIK3CA</i> point mutations and <i>ERBB2</i>...
<p>(A) Numbers of missense and nonsense mutations were compared between tumors with or without <i>NL...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
KRAS mutation testing is mandatory for patients with metastatic colorectal cancer who are eligible f...
<p>*N, total number of samples with mutation, <sup>§</sup>INS/DEL in the remaining cases.</p><p>Freq...
Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic ...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Recently a number of randomized trials have shown that patients with advanced colorectal cancer do n...
Ras is frequently mutated in cancer, however, there is a lack of consensus in the literature regardi...
DOI
Add to ORKG